Jonatan Barrera-Chimal

16PUBLICATIONS
19CO-AUTHORS
Molecular targetsMolecular medicineHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 28, 2026
Targeting the aldosterone-mineralocorticoid receptor pathway in cardiovascular-kidney-metabolic syndrome.

|Nov 26, 2025
Inhibition of MCL-1 to eliminate senescent cells and mitigate renal fibrosis in aristolochic acid nephropathy.

Peng Gao, Schrodinger Cenatus, Nathalie Henley

|Sep 05, 2025
Aldosterone synthase inhibition: a novel bullet to fight cardiovascular-kidney-metabolic syndrome.

Jonatan Barrera-Chimal, Anand Vaidya, Frederic Jaisser

|Aug 26, 2023
Kinin B1 Receptor Antagonism Prevents Acute Kidney Injury to Chronic Kidney Disease Transition in Renal Ischemia-Reperfusion by Increasing the M2 Macrophages Population in C57BL6J Mice.

Gabriel Rufino Estrela, Raisa Brito Santos, Alexandre Budu

|Oct 22, 2021
Mineralocorticoid receptor antagonists in diabetic kidney disease - mechanistic and therapeutic effects.

Jonatan Barrera-Chimal, Ixchel Lima-Posada, George L Bakris

|Oct 20, 2021
Renal fibrosis due to multiple cisplatin treatment is exacerbated by kinin B1 receptor antagonism.

A Budu, L C Freitas-Lima, A C de Arruda

Pageof 3

Frequent Collaborators

4 joint publications

Ronaldo Carvalho Araujo

3 joint publications

Leandro Ceotto Freitas-Lima

3 joint publications

Norma A Bobadilla

3 joint publications

Frederic Jaisser